Drug1st (surgical) line

Functional endoscopic sinus surgery (FESS)

Surgical polyp removal and sinus drainage

Response rate
Immediate symptom relief
Onset
Immediate
Route
Endoscopic surgery under GA
Line
1st (surgical)
IgM effect
Complete polyp removal (temporary)
Evidence level
green

Evidence summary

Gold standard surgical approach. Removes polyps, opens sinus ostia, and restores drainage. Significant symptom improvement in 80–90% of patients. However, polyp recurrence affects 40–80% of patients, with 25% requiring revision surgery. Best combined with ongoing medical/biologic therapy.

Sources (2)

T6Hopkins C et al. (2020) Long-term outcomes of endoscopic sinus surgery for CRSwNPDOI
T5Fokkens WJ et al. (2020) EPOS/EUFOREA 2020 treatment algorithm for CRSwNPDOI
Functional endoscopic sinus surgery (FESS) — Drug Profile | Kipine